Dallas, TX
June 15, 2009, 08:00 EST
Dr. Joe Duarte's Market I.Q.


The Internet's Intelligence Digest
Intelligence, Market Timing, And Trading Strategy For Traders and Investors


Obama's Gamble: Engage The Doctors
What's Hot Today:
U.S. stock futures were pointing to a lower opening on Wall Street. Asia and Europe were mostly lower overnight. Oil and gold prices moved lower again. U.S. Treasury Bond yields were lower as money moved into perceived safe bets.

Today's Economic Calendar:
  • 8:30 a.m. June Empire State Fed Manufacturing Survey: Expected: -3. Previous: -4.55.

  • 9:00 a.m. Apr Tsy International Capital: Previous: +$36.9B.

  • 1:00 p.m. Apr NAHB Housing Index: Previous: 16.
News For Thought

Iran: Election Results Spark Demonstrations, Call For Investigation. The election win by Iranian President Ahmadinejad by over 60% of the vote, raised eyebrows, both domestically and internationally. According to The Wall Street Journal: "Iran's supreme leader ordered an investigation into claims of election fraud, as the opposition vowed to march through Tehran despite a rally ban."

Chavez to close down Opposition TV Channel. In yet another sign of his move toward totalitarianism, Venezuela's president Hugo Chavez threatened to close down an opposition run television station. Chavez has been steadily nationalizing Venezuela's oil industry over the last twelve months.

Eurozone continues to slip. Even as U.S. employment data showed the potential for improvement last month, the story is much different in the Eurozone. According to The Wall Street Journal: "The number of people employed in the 16 countries that use the euro fell by 1.2 million during the first three months of the year, the largest decline since records began in 1991, data showed Monday."

Obama's Gamble: Engage The Doctors
A Dangerous Prescription Is Being Written

As corporate America cools off to President Obama's proposed health care "reform," the White House is being forced to turn to the traditional bottom rung of the health care political ladder, physicians. And if past is prelude to present, the reception is likely to be very cold.

Mr. Obama is headed home on Monday, but the welcome is uncertain in at least one place, the American Medical Association's (AMA) national convention, where the president is expected to present his case for "reform" to physicians. To be sure, the AMA is not what it used to be, with its membership having fallen to 250,000, as it has failed to stem the encroachment of the practice of medicine by managed care and government control over the last decade.

Yet, it's still a symbol, and it is looked upon by outsiders as medicine's voice in the U.S. That means that whatever happens in Chicago will be worth keeping an eye on.

Here's where things stand. The government and corporate America complain about "rising" health care costs. Yet, these rising costs are misleading as hospitals, drug companies, and equipment manufacturers have steadily increased costs as well as having received rising reimbursements throughout the years, while physicians have at best received flattening payments.

So, by most accounting, the so called "rising" costs have come from venues outside the physician's offices. And it is here where Obama sees an opportunity. There are two major carrots that he will be dangling over the doctors.

First, he has proposed to cut reimbursement to hospitals, drug makers, and insurance companies that do business with Medicare, while softly hinting that physician reimbursement won't be hit as hard.

Second, Mr. Obama is hinting that he would work toward making changes in malpractice insurance laws. According to The New York Times: "Mr. Obama has been making the case that reducing malpractice lawsuits — a goal of many doctors and Republicans — can help drive down health care costs, and should be considered as part of any health care overhaul, according to lawmakers of both parties, as well as A.M.A. officials."

This is classic divide and conquer politics, take from one group and give to the other, at least while you're trying to get something done. But as usual, the devil is in the details. And the details are not likely to be very good toward anyone.

For one thing, it's not certain what Obama means when he talks about malpractice insurance changes. And it's not certain where the cuts to reimbursements for drug companies and hospitals will come from.

More important will be what the small print says, as lawmakers, and the president will try almost certainly add loopholes to any health care legislation, giving the government lots of wiggle room to change, ammend, or even renegue on any agreements.

The financial markets are starting to sense taht health care reform is about to become Obama's first big test. And that his presidency may eventually be defined by what he does here, barring, of course, the potential for a 9/11 type event making everything else that he does moot.



Chart Courtesy of StockCharts.com


The S & P 500 has been in a consolidation pattern over the last several weeks. But as time has passed, and the White House has shown its heavy handedness in handling the subprime mortgage crisis, and the GM and Chrysler banrkuptcies, it's clear that this administration says one thing and in many cases does whatever it wants, which should make patients, doctors, nurses, drug companies, equipment makers, health insurers, and even hospital maintenance staffs and housekeepers, quite wary of what's coming down the pike.

Conclusion

Mr. Obama is going to the doctor today, figuratively and literally to some degree, as he speaks in front of the American Medical Association.

He will hint at some things that sound appealing, and will be looking for support. But, we suspect, that just as corporate America has suddenly become less helpful and cooperative, so will the physicians, despite promises of "reform" to malpractice lawsuits, and of stable reimbursement.

Many physicians we speak to on a regular basis are either winding down their practices, establishing alternative ways to get paid, such as offering cash based programs, or making investments that will make their offices more independent from hospitals, Medicare, and third party payors in general.

Medical school is no longer the draw for the bright stars that it used to be. And fewer physicians are making themselves available to the very ill or to any kind of work that requires intense after hours work.

These are trends that are now well established and that are not likely to change in the face of more uncertainty from Washington.

And the smart money is very resistant to putting big money to work in health care. Biotech, drug, and hospital stocks are all flat for the year. This is especially glaring when the Nasdaq Composite is up nearly 18% as of last Friday.

Our point is not to beat the drum for health care, or for physicians. Our point is to note that the political landscape is changing and that the change has already influenced the markets and will likely do so more as time passes and the focus on health care as the source of funding the government's deficits via higher taxes and reduced services will increase.

Politics is, after all, a mechanism for dividing the available resources. And the major resource at this point is money. Health care is a cash cow, and the White House wants to raid the larder in order to support its political agenda. The effects on the markets are not likely to be very beneficial.

Get Dr. Duarte's All NEW Books "Market Timing For Dummies." and "Trading Futures For Dummies." The Trading Manuals for All Seasons. Also Available As Kindle Books.

 



Market Moves - Stock Of The Day
Tales From The Road: Valero's (NYSE: VLO) Misleading Sinking Act
As gasoline prices rise, you'd expect the stocks of major refiners, such as Valero (NYSE: VLO) to rise as well. That is far from the truth at this point, though.



Chart Courtesy of StockCharts.com


As we headed south down I-45 this weekend, headed for the Texas Grand Slam, the annual junior tennis championships for the state, we couldn't help but to be amazed at the amount of traffic, and the prices for gasoline.

If truck and automobile traffic is a leading indicator of a strong economy, then three to six months from now we should have GDP growth above 3%. It was literally packed on the highway, with both lanes, north and south heavily populated by vehicles, especially semi-trailers, an indicator of commerce.

What makes it more interesting is that rising gasoline prices didn't seem to make a dent in the traffic. Regular was averaging above $2.60 all along the main drag, and some of the side roads we took to get to College Station.

Regular readers of "Tales of the Road" know that over the past twelve months we've traveled to many smaller markets, such as Dothan, Alabama, Waco, and Wichita Falls, Texas, as well as larger cities, such as Austin, San Antonio, and Houston, Texas. We've driven through parts of Florida, and even been to the island of Maui.

Through our travels, one factor has remained true. Smaller towns with colleges at the center of their economy have fared the recession better than other places. Tourism has also been a lifesaver for communities, with Pensacola and Maui holding up fairly well, compared to cities in the rust belt and the Northeast U.S. where industry is the leading employer.

Aside from tourism, we also noted, that Houston, whose economy is heavily tilted toward oil, was doing well despite lower oil prices.

Which brings us back to Valero, a leading U.S. refiner, whose shares are on the verge of a nervous breakdown. With oil prices having fallen, feedstock for its refiners has been cheap. And with prices falling, but demand starting to pick up, Valero and the refiners are in their sweet spot for making money.

A cruise through the news shows that Valero just did a secondary offering, raising some $270 million, which in the process has diluted its shares, just as the market looks ready to roll over into the summer non-rally for 2009.

The company is investing heavily in alternative fuels as well, recently buying ethanol facilities from a bankrupt refiner of ethanol. It's also getting more involved with renewable energy and is aggressively buying assets from the likes of Dow Chemicals.

In other words, the short term may be a bit turbulent for Valero. But, we like what it's doing. At some point, it's likely that we'll be able to pick up shares at lower prices with higher potential for appreciation. Traveling can be a thought provoking proposition.

 


Other Subscriber Reports are located on the website (log in required). These
reports are updated on a weekly basis (or as conditions require) and are not emailed:

S&P Timing & Large Cap Growth /  Bond Timing /  Dollar Timing /  Energy Timing
Gold Timing /  Fallen Angels Portfolio /  Tech Timing Models /  Health & Biotech


© Copyright 1996-2009, Kollar Market Analytics, Inc., All Rights Reserved.
  • Market IQ reports may not be redistributed without permission.
  • Disclaimer: The financial markets are risky. Investing is risky. Past performance does not guarantee future performance. The foregoing has been prepared solely for informational purposes and is not a solicitation, or an offer to buy or sell any security. Opinions are based on historical research and data believed reliable, but there is no guarantee that future results will be profitable.